1Chol H K.Composition for transdermal delivery system containing nonsteroidal anti-inflammatory drug as an active ingredient[P].Eur.Pat.App1.EP 0827741 A2,1998. 被引量：1
4Minghetti P, Casiraghi A, Cilurzo F, et al.Evaluation of adhesive properties of transdermal therapeutic systems containing nitroglycerin[J]. Boll Chim Farm, 2001, 140(2):63. 被引量：1
5Zhao H, Park DW, Kim SK, et al.The effects of pressure-sensitive adhesives and solubilizers on the skin permeation of testosterone from a matrix-type transdermal delivery system[J].Drug Dev Ind Pharm, 2002, 28(9):1125. 被引量：1
6The Draft of Chinese Pharmacopia (2015) General Chapter(中国药典2015年版通则草案)[EB/OL].2014-03-08[2014-03-15].http://wwwchporgcn/cms/newscenter/news/000603html2014. 被引量：1
7Satas D.Handbook of Pressure-Sensitive Adhesive Technology[M].USA:Van Nostrand Reinhold (Publishing Company), 1982:620. 被引量：1
8Venkatraman S, Gale R.Skin adhesives and skin adhesion.1. transdermal drug delivery systems[J].Biomaterials, 1998, 19(13):1119. 被引量：1
